000			01238 a2200361 4500
005			20250514000922.0
264		0	_c19970407
008			199704s 0 0 eng d
022			_a0887-0292
040			_aNLM _beng _cNLM
245	0	0	_aBenefits of new drugs pose unexpected dilemmas. _h[electronic resource]
260			_bAIDS alert _cMar 1997
300			_a25-7 p. _bdigital
500			_aPublication Type: Newspaper Article; Journal Article
650	0	4	_aAIDS-Related Opportunistic Infections _xdrug therapy
650	0	4	_aAcquired Immunodeficiency Syndrome _xdrug therapy
650	0	4	_aBed Occupancy
650	0	4	_aCD4 Lymphocyte Count
650	0	4	_aDisability Evaluation
650	0	4	_aPersons with Disabilities _xlegislation & jurisprudence
650	0	4	_aDrug Therapy, Combination
650	0	4	_aHIV Infections _xdrug therapy
650	0	4	_aHIV Protease Inhibitors _xtherapeutic use
650	0	4	_aHospices
650	0	4	_aHospitalization
650	0	4	_aHumans
650	0	4	_aInsurance Benefits
650	0	4	_aLength of Stay
650	0	4	_aMycobacterium avium-intracellulare Infection _xdrug therapy
650	0	4	_aSocial Security
650	0	4	_aUnited States
773	0		_tAIDS alert _gvol. 12 _gno. 3 _gp. 25-7
999			_c11296194 _d11296194